Skip to main content

Table 1 Correlation of demographics and disease characteristics

From: Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis

Parent/guardian and child demographics and disease characteristics

Total (N=136)

Not contemplating starting a CBD product for child (N=47)

Contemplating starting a CBD product for child (N=79) and using CBD product for child (N=10)

P-value

Respondent parent/guardian age in years (mean +/- SD)

 

29.7 (8)

26.5 (7)

 

Respondent Parent/guardian Gender- Female N (%)

119 (87)

42 (89)

77 (86)

 

Race/ethnicity- N (%)

 

White/Caucasian

132 (97)

44 (94)

88 (98.9)

 

Black/African American

2 (1)

1 (2)

1 (1.1)

 

Asian American

2 (1)

2 (4)

0

 

Parent/guardian education level

 

High School or GED

20 (16)

2 (4)

18 (21)

χ2= 8.03

p=0.045*

Some college but no degree

26 (19)

7 (15)

19 (22)

Associate degree

26 (19)

12 (26)

14 (16)

Bachelor’s degree or higher

62 (46)

26 (55)

36 (41)

Income level- US dollars per year

    

Less than 19,000

3 (2)

1 (2)

2 (2)

χ2= 1.34

p= 0.72

20,000 to 49,000

27 (20)

7 (15)

20 (22)

50,000 to 99,000

41 (30)

13 (28)

28 (32)

100,000 or more

65 (48)

26 (55)

39 (44)

Child’s age in years- (mean +/- SD)

 

11 (4)

11.9 (4)

 

Child gender: Female- N (%)

95 (70)

31 (66)

64 (72)

 

JIA duration N (%)

 

< 6 months

2 (1)

2 (4)

0

χ2= 1.45

p= 0.69

6-12 months

9 (7)

3 (6)

6 (6)

> 12- 24 months

20 (15)

7 (15)

13 (15)

> 24 months

105 (77)

35 (75)

70 (79)

JIA Subtype N (%)

 

Oligoarticular

47 (35)

19 (47)

28 (32)

χ2= 7.93

p= 0.13

Polyarticular

53 (39)

12 (26)

41 (46)

Psoriatic arthritis

6 (4)

3 (2)

3 (3)

Systemic

14 (10)

8 (17)

6 (7)

Ankylosing spondylitis

2 (1)

0

2 (2)

Enthesitis related arthritis

1 (0.7)

1 (2)

0

Unsure

12 (9)

3 (6)

9 (10)

Current disease activity N (%)

 

Active

59 (44)

15 (29)

44 (49)

χ2= 9.56

p= 0.022*

Inactive on medication

49 (36)

16 (34)

33 (37)

Inactive off medication for < 1 year

18 (13)

11 (23)

7 (7.8)

Clinical remission

10 (7)

5 (10)

5 (5.6)

Current medications reported using N (%)

 

None

22 (16)

10 (21)

12 (13)

χ2= 2.47

p= 0.48

NSAID

69 (51)

23 (49)

46 (51)

Non-biologic DMARD

51 (38)

18 (38)

33 (37)

Biologic DMARD

65 (48)

18 (38)

47 (52)

  1. aColumn percentages are displayed
  2. bP-values derived from the chi-squared (χ 2 ) or Wilcoxon tests
  3. cDMARDs disease-modifying antirheumatic drugs, NSAIDs nonsteroidal anti-inflammatory drugs
  4. dMedication categories are not mutually exclusive, therefore, medications do not sum to 100%